(PRME) Prime Medicine - Performance -79.1% in 12m
Compare PRME with Indices, Sectors and Commodities and Bonds. Who performs better in which timeframe?
Performance Rating
-68.65%
#100 in Group
Rel. Strength
5.58%
#7513 in Universe
Total Return 12m
-79.13%
#142 in Group
Total Return 5y
-91.28%
#116 in Group
P/E -
(?) Percentile in Group
P/E Forward -
(?) Percentile in Group
PEG -
(?) Percentile in Group
FCF Yield -
(?) Percentile in Group
12m Total Return: PRME (-79.1%) vs XBI (-11.5%)
5y Drawdown (Underwater) Chart
Top Performers in Biotechnology
Overall best picks of Peer Group Selected by proven GARP Predictive Metrics, sorted by Growth Rating
| Symbol | 1m | 12m | 5y | P/E | P/E Forward | PEG | EPS Stability |
EPS CAGR |
|---|---|---|---|---|---|---|---|---|
| UTHR NASDAQ United Therapeutics |
9.32% | 17.6% | 174% | 12.4 | 11 | 1.43 | 74.6% | 16.1% |
| HLN NYSE Haleon |
7.15% | 32% | 48.9% | 24.4 | 20.2 | 1.79 | 69.1% | 13.6% |
| AMGN NASDAQ Amgen |
-6.52% | -8.21% | 34.6% | 25.5 | 13.5 | 0.95 | 0.60% | 41% |
| LONN SW Lonza |
8.27% | 11.5% | 33.2% | 65.7 | 36 | 1.31 | 2.20% | -12.5% |
| BIM PA Biomerieux |
2.35% | 22.3% | -1.74% | 32.5 | 25.2 | 1.52 | -38.5% | -25.1% |
| NBIX NASDAQ Neurocrine Biosciences |
26.9% | -11.6% | 7.86% | 39.2 | 23.6 | 0.27 | 18.7% | -34.3% |
| KMDA NASDAQ Kamada |
8.6% | 26% | -5.07% | 27.5 | 25.1 | 1 | 32.5% | 3.93% |
| ERF PA Eurofins Scientific SE |
14.1% | 0.03% | 8.57% | 26.6 | 13.6 | 0.56 | -66.6% | -17.1% |
Performance Comparison: PRME vs XBI vs S&P 500
XBI (SPDR S&P Biotech ETF) is the Sector Benchmark for PRME
| Total Return (including Dividends) | PRME | XBI | S&P 500 |
|---|---|---|---|
| 1 Month | 0.75% | 3.80% | 8.14% |
| 3 Months | -47.45% | -11.69% | -3.09% |
| 12 Months | -79.13% | -11.47% | 13.34% |
| 5 Years | -91.28% | -19.52% | 120.03% |
| Trend Score (consistency of price movement) | PRME | XBI | S&P 500 |
| 1 Month | 9.60% | 48.1% | 90.1% |
| 3 Months | -85.1% | -81% | -66.3% |
| 12 Months | -96.9% | -54.5% | 48.9% |
| 5 Years | -97.1% | -53.8% | 84.1% |
| Relative Strength (compared with Indexes) | Rank in Peer Group | vs. XBI | vs. S&P 500 |
| 1 Month | #151 | -2.94% | -6.83% |
| 3 Month | #163 | -40.5% | -45.8% |
| 12 Month | #143 | -76.4% | -81.6% |
| 5 Years | #123 | -91.6% | -94.7% |
FAQs
Does PRME Prime Medicine outperforms the market?
No,
over the last 12 months PRME made -79.13%, while its related Sector, the SPDR S&P Biotech (XBI) made -11.47%.
Over the last 3 months PRME made -47.45%, while XBI made -11.69%.
Over the last 3 months PRME made -47.45%, while XBI made -11.69%.
Performance Comparison PRME vs Indeces and Sectors
PRME vs. Indices PRME is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| US S&P 500 | SPY | -18.1% | -7.39% | -67.3% | -92.5% |
| US NASDAQ 100 | QQQ | -19.2% | -10.3% | -68.3% | -94.5% |
| US Dow Jones Industrial 30 | DIA | -17.6% | -3.94% | -66.3% | -88.4% |
| German DAX 40 | DAX | -15.6% | -11.5% | -92.5% | -104% |
| Shanghai Shenzhen CSI 300 | CSI 300 | -17.6% | -4.98% | -67.2% | -88.1% |
| Hongkong Hang Seng | HSI | -19.7% | -13.6% | -78.3% | -89.5% |
| India NIFTY 50 | INDA | -14.7% | -5.70% | -70.7% | -84.9% |
| Brasil Bovespa | EWZ | -17.6% | -9.17% | -72.9% | -72.6% |
PRME vs. Sectors PRME is Over or Underperforming
| Symbol | 1w | 1m | 6m | 12m | |
|---|---|---|---|---|---|
| Communication Services | XLC | -16.2% | -7.22% | -71.7% | -102% |
| Consumer Discretionary | XLY | -21.3% | -10.9% | -67.6% | -99.6% |
| Consumer Staples | XLP | -14.1% | 1.59% | -70.8% | -86.5% |
| Energy | XLE | -19.7% | -6.08% | -60.6% | -72.5% |
| Financial | XLF | -17.5% | -7.14% | -72.1% | -103% |
| Health Care | XLV | -13.1% | 2.61% | -62.1% | -75.4% |
| Industrial | XLI | -18.9% | -9.74% | -68.6% | -92.9% |
| Materials | XLB | -17.3% | -5.45% | -63.5% | -75.2% |
| Real Estate | XLRE | -14.1% | -3.95% | -67.6% | -92.8% |
| Technology | XLK | -20.3% | -13.0% | -65.7% | -90.2% |
| Utilities | XLU | -14.9% | -1.91% | -72.2% | -94.5% |
| Aerospace & Defense | XAR | -16.6% | -9.15% | -75.9% | -107% |
| Biotech | XBI | -10.8% | -3.05% | -48.0% | -67.7% |
| Homebuilder | XHB | -19.1% | -9.11% | -56.2% | -74.5% |
| Retail | XRT | -20.8% | -11.0% | -63.6% | -78.4% |